Jynarque 60MG/30MG
Ended Awarded
- Contract number
- 36C24522N0097
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,298.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. was awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on October 14, 2021, for the supply of Jynarque (tolvaptan) 60mg/30mg pharmaceutical product. This firm-fixed price delivery order, valued at $10,298.57, was completed by October 15, 2021, with performance executed in Riverwoods, Illinois. The award utilized no set-aside designation, reflecting the vendor's status as an established large pharmaceutical manufacturer within the federal contracting system.
This delivery order was issued under Otsuka America Pharmaceutical Inc.'s broader $83.3 million Blanket Purchase Agreement with the VA's National Acquisition Center under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which extends through March 26, 2026. Jynarque is a specialty medication used to treat autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring specialized pharmaceutical intervention. The delivery order represents part of the VA's ongoing effort to provide critical pharmaceutical treatments to veterans across multiple Integrated Service Networks, with similar orders issued to multiple VA regions. The company maintains substantial federal supply schedule contracts totaling approximately $396 million for pharmaceuticals and hematology-related products, enabling streamlined procurement of essential medications for the Veterans Health Administration.
Quick answers
Who was awarded contract 36C24522N0097?
36C24522N0097 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 14, 2021.
How much is contract 36C24522N0097 worth?
The government has obligated $10,299 on 36C24522N0097.
Is contract 36C24522N0097 an order under another contract?
Yes. 36C24522N0097 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24522N0097 competed?
The extent of competition for 36C24522N0097 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award